Aveo appoints CFO
This article was originally published in Scrip
Executive Summary
Cambridge, Massachusetts-based Aveo Oncology has appointed Keith S Ehrlich chief financial officer. Mr Ehrlich will be responsible for the company's financial and administrative strategy and management, and will serve on the executive leadership team. He will report to Michael Bailey, Aveo's president and CEO. Mr Ehrlich was most recently CFO of Synta Pharmaceuticals. Prior to Synta, he held various senior finance and audit roles, including CFO of Argentys, Dyax and OraVax, director of finance of Vertex Pharmaceuticals and senior audit manager with PricewaterhouseCooper.